Novadaq 2005 - 2017
Svp, Regulatory, Clinical and Economic Affairs  Vp, Marketing | Vp, Product Development
Stryker 2005 - 2017
Senior Director, Drug Product Programs  Organizational Leadership  Acquisition Integration
Chase Medical 2002 - 2005
Director of Market Development  Product Marketing  Clinical Trials  New Product Education
Armus Corporation 2000 - 2001
Vice President, Business Development  Revenue Growth  Organizational Transformation
Cardiopulmonary Research Science and Technology Institute 1997 - 2000
Executive Director | Chief Operating Officer  Entrepreneurship  Quality Control Program Design
Education:
University of Nevada Las Vegas
University of Nevada
Masters
University of Nevada
Bachelors, Bachelor of Arts
University of Nevada - Las Vegas
Masters, Master of Arts, Public Law, Political Science
University of Nevada - Las Vegas
Bachelors, Bachelor of Arts, Political Science
Skills:
Medical Devices Market Development Capital Equipment Healthcare Cardiology Product Development Commercialization Operating Room Hospitals Medical Imaging Clinical Research Surgeons Vascular Strategy Surgery Global Marketing R&D Surgical Device Sales Fda Iso 13485 Start Ups Biomedical Engineering Product Management Managed Care Sales Effectiveness Digital Imaging Cross Functional Team Leadership Surgical Instruments Endoscopy Orthopedic Biotechnology Product Marketing Design Control Lifesciences Pharmaceutical Industry Regulatory Affairs Hardware Diagnostics Capa Clinical Trials Urology Oncology Radiology Gastroenterology Cardiac Surgery Disposables Interventional Cardiology Interventional Radiology Neurosurgery Spine Product Launch
Methods and systems for characterizing tissue of a subject include acquiring and receiving data for a plurality of time series of fluorescence images, identifying one or more attributes of the data relevant to a clinical characterization of the tissue, and categorizing the data into clusters based on the attributes such that the data in the same cluster are more similar to each other than the data in different clusters, wherein the clusters characterize the tissue. The methods and systems further include receiving data for a subject time series of fluorescence images, associating a respective cluster with each of a plurality of subregions in the subject time series of fluorescence images, and generating a subject spatial map based on the clusters for the plurality of subregions in the subject time series of fluorescence images. The generated spatial maps may then be used as input for tissue diagnostics using supervised machine learning.
Name / Title
Company / Classification
Phones & Addresses
Lori Swalm Partner
MEDICAL OUTCOMES REPORTING AND EVALUATIONS, LLC Secretarial/Court Reporting